Monday November 16th, 2020
Vaccine news and robust Asian data see’s risk-on sentiment return to markets. Moderna reported its vaccine effectiveness is 94.5% from its phase 3 trials, joining Pfizer and BioNTech, and Britain’s AstraZeneca is also conducting a phase 3 trial. China’s industrial output exceeds expectatio...